The breakpoint cluster region site in patients with Philadelphia chromosome–positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations
Abstract
Background. The breakpoint site of the breakpoint cluster region (bcr) has been correlated with patient characteristics, with the disease phase, and with the prognosis of patients with chronic myelogenous leukemia (CML), but the findings remain controversial. Methods. Appropriate restriction enzymes and the 3′ and universal probes were used to map the breakpoint site by Southern blot analysis into 5′ and 3′ breakpoints and a breakpoint in zone 3 (or fragment 2) in 362 patients in different phases of CML (238 in early chronic phase, 69 in late chronic phase, 31 in accelerated phase, and 24 in blastic phase). Standard statistical methods were used to evaluate differences in characteristics and in prognosis by the breakpoint site. Results. No correlation was noted between CML phases and breakpoint site. Among patients in the early chronic phase, thrombocytosis was significantly associated with the 3′ breakpoint site (P = 0.02), whereas peripheral basophilia occurred more frequently with the 5′ breakpoint site (P = 0.05). Other patient and disease characteristics were similar in frequency among the breakpoint-site subgroups. There was no difference in response to alpha-interferon therapy (186 patients treated) by the breakpoint site. Survival, dated from either referral to the authors' institution or from diagnosis, was not significantly different among patients with early chronic phase CML by the breakpoint site. However, patients with a 3′ deletion tended to have a shorter survival. Conclusion. Determination of the breakpoint site by Southern blot analysis does not help to predict prognosis of patients with CML. Cancer 1995;76:992–7.Keywords
This publication has 33 references indexed in Scilit:
- Chronic myelogenous leukemia: a concise updateBlood, 1993
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaThe American Journal of Medicine, 1990
- Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reactionBlood, 1989
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemiaBlood, 1987
- Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused geneCell, 1986
- Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalBlood, 1985
- Prognostic discrimination in "good-risk" chronic granulocytic leukemiaBlood, 1984
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973